SMARCA4 and cancer: Because LADC cells, as well as several other cancer types, frequently carry homozygous SMARCA4-inactivating mutations (9,10,42,59–62), the identification of vulnerabilities caused by loss of SMARCA4 expression that result in synthetic lethal relationships may be useful for developing treatment strategies for this type of cancer.